Human medicines European public assessment report (EPAR): Azacitidine Accord, azacitidine, Myelodysplastic Syndromes,Leukemia, Myelomonocytic, Chronic,Leukemia, Myeloid, Acute, Date of authorisation: 13/02/2020, Status: Authorised

Human medicines European public assessment report (EPAR): Azacitidine Celgene, azacitidine, Myelodysplastic Syndromes,Leukemia, Myelomonocytic, Chronic,Leukemia, Myeloid, Acute, Date of authorisation: 02/08/2019, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1a2ec7d ◽

2019 ◽

Author(s):

Keyword(s):

Myelodysplastic Syndromes ◽

Assessment Report ◽

Chronic Leukemia ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Vidaza, azacitidine, Myelodysplastic Syndromes, Date of authorisation: 17/12/2008, Revision: 18, Status: Authorised

Case Medical Research ◽

10.31525/cmr-3996bd ◽

2019 ◽

Author(s):

Keyword(s):

Myelodysplastic Syndromes ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Revlimid, lenalidomide, Multiple Myeloma,Lymphoma, Mantle-Cell,Myelodysplastic Syndromes, Date of authorisation: 14/06/2007, Revision: 37, Status: Authorised

Case Medical Research ◽

10.31525/cmr-95e8ed ◽

2019 ◽

Author(s):

Keyword(s):

Multiple Myeloma ◽

Myelodysplastic Syndromes ◽

Assessment Report ◽

European Public ◽

Mantle Cell ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Vidaza, azacitidine, Myelodysplastic Syndromes, Date of authorisation: 17/12/2008, Revision: 18, Status: Authorised

Case Medical Research ◽

10.31525/cmr-fe2418 ◽

2019 ◽

Author(s):

Keyword(s):

Myelodysplastic Syndromes ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Revlimid, lenalidomide, Multiple Myeloma,Lymphoma, Mantle-Cell,Myelodysplastic Syndromes, Date of authorisation: 14/06/2007, Revision: 38, Status: Authorised

Case Medical Research ◽

10.31525/cmr-962c32 ◽

2019 ◽

Author(s):

Keyword(s):

Multiple Myeloma ◽

Myelodysplastic Syndromes ◽

Assessment Report ◽

European Public ◽

Mantle Cell ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Fabrazyme, agalsidase beta, Fabry Disease, Date of authorisation: 03/08/2001, Revision: 26, Status: Authorised

Case Medical Research ◽

10.31525/cmr-19715f1 ◽

2019 ◽

Author(s):

Keyword(s):

Fabry Disease ◽

Agalsidase Beta ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Controloc Control, pantoprazole, Gastroesophageal Reflux, Date of authorisation: 11/06/2009, Revision: 11, Status: Authorised

Case Medical Research ◽

10.31525/cmr-193042d ◽

2019 ◽

Author(s):

Keyword(s):

Gastroesophageal Reflux ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Striascan, ioflupane (123i), Radionuclide Imaging,Dementia,Movement Disorders, Date of authorisation: 25/06/2019

Case Medical Research ◽

10.31525/cmr-193042a ◽

2019 ◽

Author(s):

Keyword(s):

Radionuclide Imaging ◽

Movement Disorders ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Rivastigmine Hexal, rivastigmine, Dementia,Alzheimer Disease,Parkinson Disease, Date of authorisation: 11/12/2009, Revision: 10, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1930425 ◽

2019 ◽

Author(s):

Keyword(s):

Alzheimer Disease ◽

Parkinson Disease ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report

Download Full-text

Human medicines European public assessment report (EPAR): Ribavirin Mylan (previously Ribavirin Three Rivers), ribavirin, Hepatitis C, Chronic, Date of authorisation: 10/06/2010, Revision: 10, Status: Authorised

Case Medical Research ◽

10.31525/cmr-1907582 ◽

2019 ◽

Author(s):

Keyword(s):

Hepatitis C ◽

Assessment Report ◽

European Public ◽

European Public Assessment Report ◽

Three Rivers

Download Full-text